The outlook for the China irritable bowel syndrome treatment market remains positive as healthcare awareness, pharmaceutical developments, and demand for improved symptom management continue to influence the sector. Market Research Future estimates that the market will increase from USD 157.31 million in 2024 to USD 170.1 million in 2025, reaching USD 371.62 million by 2035. This forecast...
